Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Salicylic acid nitroalkene - Eolo Pharma

Next Previous
Drug Profile

Salicylic acid nitroalkene - Eolo Pharma

Alternative Names: MVD-1

Latest Information Update: 20 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eolo Pharma
  • Class Alkenes; Antihyperglycaemics; Antihypertensives; Hepatoprotectants; Nitro compounds; Obesity therapies; Salicylic acids; Small molecules
  • Mechanism of Action Energy metabolism stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Obesity
  • Preclinical Hypertension; Non-alcoholic steatohepatitis; Type 2 diabetes mellitus

Most Recent Events

  • 20 Jun 2025 Preclinical trials in Hypertension in USA (PO), before June 2025 (Eolo Pharma pipeline, June 2025)
  • 20 Jun 2025 Preclinical trials in Non-alcoholic steatohepatitis in USA (PO), before June 2025 (Eolo Pharma pipeline, June 2025)
  • 16 Jun 2025 Efficacy and adverse events data from a phase Ia/b trial in Obesity released by Eolo Pharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top